[ad_1]
Aptar Pharma has announced the launch of a new disease management platform to support patients in their medical journey. This new platform is expanding. Aptar Pharma’s portfolio of digital health solutions A complete, end-to-end solution, supporting patients from prevention and diagnostic stages, to disease management and more, across multiple medical areas.
Using Aptar Digital Health’s disease management platform, care teams can access real-time remote data monitoring to monitor patient adherence to their treatment. In addition, patients will benefit from remote patient diagnostic features, ePROS (Electronic Patient Reported Outcomes), virtual care and telehealth solutions, symptom and trigger monitoring, as well as access to educational content and videos.
The disease management platform reflects Aptar Digital Health’s commitment to providing compliant, innovative and in-class solutions to facilitate home care for chronic patients. With this comprehensive and easy-to-use platform, patients can benefit from proactive monitoring of disease progression and easy communication with their care teams, with the ultimate goal of helping patients optimize their treatment for better health outcomes.
“Aptar Pharma acquisitions Cohero health And Voluntarily Gael Tuya, President, Aptar Pharma, said, “It has enabled us to expand our digital health expertise. “We aim to reduce gaps in healthcare by empowering patients, improving patient care, and strengthening patient-care team communication by providing all-in-one solutions including medication delivery connected devices, digital therapeutics and care services.”
“With this new platform, we are accelerating the pace of change for digital healthcare solutions,” said Sai Shankar, President, Aptar Digital Health. “Aptar Digital Health’s mission is to enhance patient experiences by providing continuous support and decentralized care. The new offering strengthens our expertise in the field by providing a responsive solution for patients at every stage of their journey.”
Aptar’s digital health disease management platform is a new commercial offering for its life sciences industry partners, payers and providers, and integrates long-term therapies for patients with chronic conditions.
Download full press release over here.
[ad_2]
Source link
